HORMONE-RESISTANT PROSTATE CANCER
Clinical trials for HORMONE-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a special diet make chemotherapy easier and more effective?
Disease control OngoingThis study is testing whether eating a special, low-calorie diet before and during chemotherapy can help reduce side effects and make the treatment work better. It involves 130 people with breast cancer or prostate cancer who are receiving specific chemotherapy drugs. Participant…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 21:25 UTC
-
New hope for tough prostate cancer: adding immunotherapy when standard drug fails
Disease control OngoingThis study is testing if adding the immunotherapy drug pembrolizumab can help control advanced prostate cancer that has started growing again despite treatment with the standard drug enzalutamide. It involves about 58 men whose cancer has spread and is no longer responding to hor…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Scientists hunt for genetic clues in prostate cancer treatment
Knowledge-focused OngoingThis study aims to understand how genetic changes in prostate cancer tumors relate to treatment response. Researchers collect tissue, blood, and urine samples from 92 men with advanced prostate cancer before and during standard treatment. By analyzing these samples, they hope to …
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC